Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Elisa, Capizzi"'
Autor:
Karim Rihawi, Roberta Alfieri, Michelangelo Fiorentino, Francesca Fontana, Elisa Capizzi, Andrea Cavazzoni, Mario Terracciano, Silvia La Monica, Alberto Ferrarini, Genny Buson, Pier Giorgio Petronini, Andrea Ardizzoni
Publikováno v:
Translational Oncology, Vol 12, Iss 1, Pp 116-121 (2019)
INTRODUCTION: Translocations of the anaplastic lymphoma kinase (ALK) can be effectively targeted in advanced non-small cell lung cancer by ALK-TKI inhibitors including Crizotinib. However, the development of acquired resistance often limits the durat
Externí odkaz:
https://doaj.org/article/048a768f22a043d68188d83a79e96d61
Autor:
Costantino Ricci, Elisa Capizzi, Francesca Giunchi, Laura Casolari, Francesco Gelsomino, Karim Rihawi, Filippo Natali, Vanina Livi, Rocco Trisolini, Michelangelo Fiorentino, Andrea Ardizzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Introduction: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is curr
Externí odkaz:
https://doaj.org/article/0e4de554e2c1485b8467227e5c5680aa
Autor:
Lidia Gatto MD, Massimo Del Gaudio MD, Matteo Ravaioli, Matteo Cescon, Valeria Tonini MD, Maurizio Cervellera MD, Alessandro Franceschelli MD, Maria Giulia Pirini MD, Valerio Di Scioscio MD, Francesco Buia MD, Fabio Niro MD, Elisa Capizzi MD, Michelangelo Fiorentino, Annalisa Astolfi PhD, Valentina Indio PhD, Margherita Nannini MD, Maria Abbondanza Pantaleo, Maristella Saponara MD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Background: Primary soft tissue sarcomas arising from the male urinary and genital tract are rare tumors, only accounting for 1% to 2% of all malignancies of the genitourinary tract. Clinical management of advanced disease is lacking in standardized
Externí odkaz:
https://doaj.org/article/b52cc74181b4492ca44729b165e97f02
Autor:
Tania Franceschini, Francesca Giunchi, Veronica Mollica, Annalisa Altimari, Elisa Capizzi, Mattia Banfi, Riccardo Schiavina, Michelangelo Fiorentino, Francesco Massari
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 184 (2021)
The occurrence of kidney oncocytic lesions with an admixed papillary component is not unusual in routine pathology practice. These neoplasms with dual morphology are classically recognized as collision tumors with variable malignant potential. Using
Externí odkaz:
https://doaj.org/article/274a3f3616604049a1bfb60e9b1a0452
Autor:
Francesca Giunchi, Tania Franceschini, Elisa Gruppioni, Annalisa Altimari, Elisa Capizzi, Francesco Massari, Riccardo Schiavina, Matteo Brunelli, Guido Martignoni, Michelangelo Fiorentino
Publikováno v:
Diagnostics, Vol 10, Iss 2, p 123 (2020)
Background: Clear cell tubulo-papillary renal cell carcinoma (cctpRCC) is characterized by clear cell morphology, but differs from conventional clear cell carcinoma (ccRCC) for its indolent clinical behavior and genetic background. The differential d
Externí odkaz:
https://doaj.org/article/d16d5aab589e44ac8c5bbbd4e62b8398
Autor:
Francesco, Facchinetti, Francesca, Bozzetti, Letizia, Gnetti, Roberta, Minari, Pellegrino, Crafa, Sara Elena, Rebuzzi, Roberto, Ferrara, Elisa, Gruppioni, Elisa, Capizzi, Ermanno, Giombelli, Girolamo, Crisi, Annalisa, Altimari, Marcello, Tiseo
Publikováno v:
JCO precision oncology. 3
Autor:
Francesca Ambrosi, Francesca Giunchi, Elisa Capizzi, Alessandra Cancellieri, Rocco Trisolini, Andrea Ardizzoni, Michelangelo Fiorentino, Costantino Ricci
Background: The PD-L1 assessment is mandatory for the selection of patients affected by advanced non-small-cell lung cancer (NSCLC) who can benefit from the PD-1/PD-L1 checkpoint inhibitors therapy. Previous studies tested PD-L1 on cytological smears
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a70e5b8505464bdd4632561e5816be
http://hdl.handle.net/11585/886056
http://hdl.handle.net/11585/886056
Autor:
Marcello Tiseo, Francesco Facchinetti, Francesca Bozzetti, Roberta Minari, Annalisa Altimari, Letizia Gnetti, Pellegrino Crafa, Elisa Capizzi, Ermanno Giombelli, Girolamo Crisi, Roberto Ferrara, Elisa Gruppioni, Sara Elena Rebuzzi
Publikováno v:
JCO Precision Oncology. :1-7
Autor:
Giovanni Tallini, Alessandra Cancellieri, Filippo Natali, Andrea Ardizzoni, Elisa Capizzi, Rocco Trisolini, Dario de Biase, Michelangelo Fiorentino, Marco Ferrari, Daniela Paioli, Vanina Livi
Publikováno v:
The Clinical Respiratory Journal. 13:590-597
INTRODUCTION AND OBJECTIVES: Endosonography is increasingly used for the diagnosis of centrally located, bronchoscopically invisible intrapulmonary lesions, but data regarding its utility for molecular profiling are lacking. We aimed to assess the su
Autor:
Andrea Ardizzoni, Francesco Gelsomino, Costantino Ricci, Claudio Ceccarelli, Michelangelo Fiorentino, Laura Casolari, Elisa Capizzi, Francesca Giunchi, Stefano Zagnoni, Begoña Urrios Álvarez Gómez, Rocco Trisolini
Publikováno v:
Lung Cancer. 126:9-14
Introduction The assessment of PD-L1 expression by immunohistochemistry is mandatory for the administration as first-line therapy of the anti PD-1 check-point inhibitor Pembrolizumab in patients with advanced non-small-cell lung cancer (NSCLC). Curre